Regulation of vascular tone involves the close interaction between endothelial and smooth muscle cells in the vessel wall. Abnormal vessel tone and structure underlie the pathophysiology of such important diseases as pulmonary hypertension and atherosclerosis. Hypoxia may play an important role in the pathogenesis of pulmonary hypertension by activating the expression of specific genes in human vascular endothelial cells resulting in the elaboration of protein products able to induce vasoconstriction, smooth muscle cell hyperplasia, and matrix remodeling. In addition, their recent studies show that hypoxia has direct effects on the smooth muscle cells (SMC), which in turn, can release mediators that regulate gene expression in the endothelial cells (EC). Vascular SMC cultured in a hypoxic environment demonstrated a seven-fold increase in the expression of the heme oxygenases-p1 (NO-1) mRNA and protein. HO catalyzes the breakdown of heme to yield carbon monoxide (CO) and biliverdin. Like NO, CO is a molecule that activates quanylate cyclase resulting in elevated cGMP levels. Increased CGMP levels in the vasculature causes SMC relaxation. It is hypothesized that SMC-derived CO is a regulator of vascular tone under physiologic and pathophysiologic (such s hypoxic) conditions, SMC-derived CD can increase intracellular cGMP levels in an autocrine manner or it can regulate the expression of potent vasoactive mediators produced by E C such as endothelin and PDGF which then control SMC growth in a paracrine manner.
The aims of this proposal are: To study the physiologic role of CO on EC and SMC function under normoxic and hypoxic conditions, and to examine molecular mechanisms controlling HO-gene expression in hypoxic vascular SMC. The long-term expectation is the an understanding of hypoxic vascular SMC. The long-term expectation is that an understanding of the basic molecualr mechanisms responsible for control vascular tone will load to new therapies to enhance the body a adaptive response s to hypoxia.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL055454-03
Application #
2771471
Study Section
Pathology A Study Section (PTHA)
Project Start
1996-09-01
Project End
1999-08-31
Budget Start
1998-09-01
Budget End
1999-08-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Willis, Gareth R; Fernandez-Gonzalez, Angeles; Anastas, Jamie et al. (2018) Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation. Am J Respir Crit Care Med 197:104-116
Christou, Helen; Hudalla, Hannes; Michael, Zoe et al. (2018) Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model. J Pharmacol Exp Ther 364:258-274
Willis, Gareth R; Mitsialis, S Alex; Kourembanas, Stella (2018) ""Good things come in small packages"": application of exosome-based therapeutics in neonatal lung injury. Pediatr Res 83:298-307
Willis, Gareth R; Kourembanas, Stella; Mitsialis, S Alex (2017) Toward Exosome-Based Therapeutics: Isolation, Heterogeneity, and Fit-for-Purpose Potency. Front Cardiovasc Med 4:63
Mitsialis, S Alex; Kourembanas, Stella (2016) Stem cell-based therapies for the newborn lung and brain: Possibilities and challenges. Semin Perinatol 40:138-51
Kourembanas, Stella (2014) Expanding the pool of stem cell therapy for lung growth and repair. Circulation 129:2091-3
Hale, Andrew; Lee, Changjin; Annis, Sofia et al. (2014) An Argonaute 2 switch regulates circulating miR-210 to coordinate hypoxic adaptation across cells. Biochim Biophys Acta 1843:2528-42
Xiao, Yongguang; Christou, Helen; Liu, Li et al. (2013) Endothelial indoleamine 2,3-dioxygenase protects against development of pulmonary hypertension. Am J Respir Crit Care Med 188:482-91
Hansmann, Georg; Fernandez-Gonzalez, Angeles; Aslam, Muhammad et al. (2012) Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension. Pulm Circ 2:170-81
Christou, Helen; Reslan, Ossama M; Mam, Virak et al. (2012) Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 302:L875-90

Showing the most recent 10 out of 35 publications